Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EU First, US Second For Product Launch? Not Necessarily, Says French Investor

This article was originally published in The Gray Sheet

Executive Summary

As US medical device regulations moderate and EU regulations start to become more stringent, companies have a harder decision to make about which of the two markets they should target for initial launch of their products, says Thierry Chignon, senior partner at Mérieux Développement.


Related Content

EU Policy-Makers Set End-Of-Year Goal To Finalize Device, Dx Reform


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst